| Dr Salome L Lulusa, | |
|
2220 Hewatt Rd, Snellville, GA 30039 | |
| (770) 978-6276 | |
| Not Available |
| Full Name | Dr Salome L Lulusa |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2220 Hewatt Rd, Snellville, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063796035 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH025655 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Salome L Lulusa, 1205 Bramlett Creek Place, Lawrenceville, GA 30045 Ph: () - | Dr Salome L Lulusa, 2220 Hewatt Rd, Snellville, GA 30039 Ph: (770) 978-6276 |
News Archive
Vital Images, Inc., a leading provider of advanced visualization and analysis software, announced today that it is collaborating with Arkansas Children's Hospital of Little Rock, Ark., to develop a Vitrea® pediatric cardiac application. The software is an advanced visualization tool designed specifically to meet the unique cardiac features and patient care requirements presented by pediatric patients.
Cambridge Heart, Inc., a developer of noninvasive diagnostic tests for cardiac disease, today announced the launch of its Microvolt T-Wave Alternans (MTWA) technology as an integrated part of industry-leading cardiac stress test systems manufactured and distributed by Cardiac Science Corporation. The MTWA technology, which can predict a patient's risk of sudden cardiac arrest (SCA), is now being offered to new and existing users of Cardiac Science's Quinton Q-Stress cardiac stress systems.
In this post in Global Health Frontline News' "Notes From the Field" blog, Kevin Cain, chief of the tuberculosis (TB) branch for a research and public health collaboration between the Kenya Medical Research Institute (KEMRI) and the CDC in Kisumu, Kenya, reports on TB research underway as part of the collaboration.
Conditions such as Parkinson's disease are a result of pathogenic changes to proteins. In the neurodegenerative condition of Parkinson's disease, which is currently incurable, the alpha-synuclein protein changes and becomes pathological. Until now, there have not been any antibodies that could help to demonstrate the change in alpha-synuclein associated with the disease. An international team of experts led by Gabor G. Kovacs from the Clinical Institute of Neurology at the MedUni Vienna has now discovered a new antibody that actually possesses this ability.
› Verified 7 days ago
Hoang Truong, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1938 Scenic Hwy N, Snellville, GA 30078 Phone: 770-979-0922 | |
Michelle Anemana, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1938 Scenic Hwy N, Snellville, GA 30078 Phone: 770-979-0922 | |
Hiral Patel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1905 Scenic Hwy N, Ste 4000, Snellville, GA 30078 Phone: 770-978-5806 | |
Ruth Ellen Dunbar, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3435 Centerville Hwy, Snellville, GA 30039 Phone: 770-972-3135 | |
Mrs. Thu Vu Hoang, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2220 Hewatt Rd, Snellville, GA 30039 Phone: 770-978-6276 | |
David Kirtland, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3550 Centerville Hwy, Snellville, GA 30039 Phone: 770-736-7806 Fax: 770-736-9949 |